INTRODUCTION
A ntiretroviral therapy (ART) is usually a triple combination regimen of two nucleoside reverse transcriptase inhibitors (NRTIs) plus one non-nucleoside reverse transcriptase inhibitors (NNRTIs) or protease inhibitors in Nigeria. ART has been shown to maximally and durably suppress viral replication, and restore and/or preserve immune function as refl ected by CD4 cell measures, thereby signifi cantly reducing morbidity and mortality associated with HIV infection, improving quality of life of HIV-infected patients and reduce risk of HIV transmission [1, 2] . However, ART is also associated with toxicities from the individual antiretroviral drugs in the regimen like any other drugs. Anaemia, hepatotoxicity, vomiting, peripheral neuropathy, diarrhoea, dizziness, paraesthesia, bad dreams and skin rash were common ADRs observed in patients on ART [3] [4] [5] [6] . Other toxicities include lipodystrophy, lactic acidosis, and hyperlipidemia amongst others. Th ese druginduced toxicities not only have the potential to diminish quality of life of the patients but can adversely aff ect treatment adherence by patients' refusal to take any ART for fear of toxicity [7] [8] [9] . Poor adherence to ART is associated with development of drug-resistant human immunodefi ciency virus, increased disease progression and virologic failure; consequently, morbidity and mortality as well as the burden on health care increases [10] [11] [12] . WHO defi ned pharmacovigilance as "science and activities relating to the detection, assessment, understanding and prevention of adverse eff ects or any other drug related problems". Th e ultimate goal of pharmacovigilance is to ensure safe and rational use of medicines, and prevent avoidable negative consequences of pharmacotherapy in patients [13] . Pharmacovigilance programs have led to regulatory decision to withdraw of several approved and licensed drugs from the market because of druginduced toxicities [14, 15] . However, under-reporting of adverse drug reactions (ADRs) is one of the major problems associated with pharmacovigilance programs. Recent studies provided evidence of signifi cant and widespread under-reporting of ADRs to spontaneous reporting systems including serious or severe ADRs [16] . It is likely that less than 10% of serious reactions are reported [14, 17] . In many countries including Nigeria, the reporting rates are likely to be much lower [18] . Studies conducted in diff erent settings including Nigeria reported poor knowledge, attitude and practices to ADR monitoring and reporting among healthcare professionals [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . High patient load, indiff erence, unavailability and/or inaccessibility of the ADR reporting form, lack of incentives for the reporters, not knowing what to report or even who should report and fear of allegation for reporting errors were factors that may responsible for the low reporting rates. Sometimes healthcare professionals fear that the acknowledgement of adverse reactions may refl ect negatively on their competence or put them at risk of litigation. Some are reluctant to report *Corresponding Author E-mail: agkenneth@gmail.com ABSTRACT Under-reporting of ADR may be associated with poor knowledge, attitudes and practices to pharmacovigilance. This study evaluated knowledge, attitudes and practices of healthcare professionals about ADR monitoring and reporting following interventions. This longitudinal study included 36 healthcare professionals participating in ART program in a tertiary hospital. Interventions included group training on pharmacovigilance (PV) and provision of ADR reporting forms amongst others. Assessments were conducted at months 0 and 6 post-interventions using study-specific Likerttype instruments. Mean attitude scores above midpoint of 3.6 on 5-point scale were regarded as positive and below as negative. P<0.05 used to determine statistical significance. Mean age of participants was 36.6 (95%CI, 34.5-38.7) years; 61.1% males; 44.4% doctors, 13.9% pharmacists, 19.4% nurses, 8.3% laboratory scientists, 8.3% record officers and 5.6% welfare officers. None had received training on PV previously. Mean knowledge test score increased from 53.6% (95%CI, 44.6-63.6) at pre-intervention to 77.1% (95%CI, 72.8-81.4) at post-intervention with a mean change of 146.9% (95%CI, 60.5-233.3; p=0.000). Mean rated attitude scores increased from 3.6 (95%CI, 3.4-3.8) at pre-intervention to 4.2 (95%CI, 4.0-4.4) at post-intervention; the difference was statistically significant (p=0.000). 75.8% reported that ADR reporting forms were not readily available at pre-intervention compared to 18.2% at postintervention; 15.2% had reported ADR previously at pre-intervention compared to 69.7% at post-intervention; 12.1% reported providing information regarding ADRs and its management always at pre-intervention compared to 45.5% at post-intervention; these differences were statistically significant (p<0.05). Lack/inadequate knowledge, unavailability of reporting forms and negative attitudes were barriers identified; and addressing them resulted in significant improvement in this setting. Scaling up these interventions to other hospitals can better the situation of under-reporting of ADRs in Nigeria.
adverse reactions because of doubts regarding the causal role of the drug. Th e commonest factors that militate against ADR reporting were lack of knowledge, unavailability of reporting forms, ignorance of the reporting procedure and indiff erence to ADRs reporting [18, 24, 25] . Majority of health workers were willing to practice pharmacovigilance if they are trained [25, 26] .
It is vital that the safety of all medicines is monitored throughout its clinical use. Clarity of criteria for reporting, simple procedures and good motivational practice may be infl uential in addressing the problems in some if not all settings [29] . Improving the knowledge, attitudes and practices of healthcare professionals regarding ADR monitoring and reporting can better the situation of under-reporting of ADRs. Th is study evaluated the change in knowledge, attitudes and practices of healthcare professionals about ADR monitoring and reporting after six months of capacity building interventions in a Nigerian tertiary hospital.
METHODS

Research Design
Th is was a longitudinal study that aimed to improve the knowledge, attitudes and practices of healthcare professionals about monitoring and reporting of ADR related to antiretroviral therapy (ART) in a public health facility in Nigeria. Th e healthcare professionals included medical doctors, pharmacists, nurses, laboratory scientists, medical record offi cers and social welfare offi cers participating in the ART program in the study site. Th ere was a baseline assessment of the knowledge, attitudes and practices of healthcare professionals in the ART programs about monitoring and reporting of ADR related to ART using a semi-structured and study-specifi c instrument. Th e post-intervention assessment of the knowledge, attitudes and practices of same healthcare professionals about monitoring and reporting of ADRs was done after 6 months.
Setting
Th e study was conducted in Federal Medical Center (FMC) Owo, Ondo State, Nigeria. Th is is a 300 bed-capacity tertiary health facility and serves both insured and uninsured members of the general public within and outside the State. HIV comprehensive care services including ART are provided at no cost to the patients with funding support from PEPFAR through USAID. Th e healthcare professionals involved in the ART program were trained on HIV Comprehensive Care Services based on the Nigerian National HIV/AIDS treatment guidelines at commencement. Th e training package included topics as adverse eff ects of antiretroviral drugs without emphasis on ADR monitoring and reporting.
Intervention
Th e interventions included a fi ve-day group training of the healthcare professionals (doctors, pharmacists, laboratory scientists, nurses, medical record offi cers and social welfare offi cers) on clinical pharmacovigilance for antiretroviral drugs using a standardized training manual available at: http://www.nafdac.gov.ng/index.php?option=comdocman &task=catview&gid=53&Itemid =57. Th e training was facilitated by the researchers and three trained assistants. A multidisciplinary Hospital-based ART Pharmacovigilance Committee (HAPC) that included medical doctors, pharmacists, nurses, medical record offi cer, laboratory scientists and social welfare offi cers was constituted and inaugurated by hospital management. HAPC was mandated to coordinate pharmacovigilance of antiretroviral drugs in the health facility. HAPC holds monthly feedback and safety data review meetings; and follow up patients with individual case safety reports (ICSRs) and submit to ICSRs to the National Pharmacovigilance Center. Standard Operating Procedure (SOP) for detection, evaluation and reporting ADRs related to ART that included the ADR screening form and a fl owchart for ADR monitoring and reporting was disseminated and adopted by the health facility. Th e national ADR reporting form (the yellow form) was also provided for reporting of suspected ADRs (ICSRs) to the National Pharmacovigilance center at NAFDAC. Th e copies of ADR screening and reporting tools were deployed to all service delivery points through the hospital medical record system. Th e healthcare workers were also trained on the use of the job aids and tools. No monetary incentive was provided to the health workers involved in the study. After interventions, there was a monthly follow up monitoring of hospital pharmacovigilance program and provision of technical assistance as appropriate by the researcher.
Selection Criteria
All healthcare professionals (medical doctors, pharmacists, nurses, laboratory scientists, medical record offi cers and social welfare offi cers) participating in the ART program in the study site and consented to participate were eligible to be included in the study. Th e healthcare professionals who are involved in the ART program but unwilling to participate in the study, those who are not involved in the ART program or on leave or absence from duty during the study period were excluded. All other workers who are not medical doctors, pharmacists, nurses, laboratory scientists, medical record offi cers and social welfare offi cers in the study site were excluded.
Study Population, Sample and Sampling Methods
Th e study site was selected using purposive sampling technique. Th e population for the study included all 36 healthcare professionals (16 medical doctors, 5 pharmacists, 7 nurses, 3 laboratory scientists, 3 medical record offi cers and 2 social welfare offi cers) participating in the ART program. All the healthcare professionals participating in the ART program were purposively selected for the study.
Validity and Reliability of Instrument
Th e study-specifi c knowledge, attitude and practices (KAP) questionnaire was circulated to the technical experts and a biostatistician. It was discussed objectively and modifi ed based on the feedbacks for content validity. In addition, it was pre-tested which also provided opportunity for the modifi cation and validation of the study instrument. Th e site and participants involved in the pre-testing of the instrument were not included in the main study to avoid bias. Th e characteristics of the healthcare professionals used in the pre-testing were similar to the selected study participants.
Ethical Consideration
Th e ethical approval for this study was obtained from National Health Research Ethics Committee (NHREC), Abuja, Nigeria. Informed consent of the participants was also obtained. Confi dentiality was assured by excluding participants' identifi er during analysis.
Data Collection
Th e instruments included semi-structured and study-specifi c KAP questionnaire that employed mainly a Likert-type scale, pre-and posttraining questionnaire and participants' training evaluation form. Th e KAP questionnaire was administered to the study participants (medical doctors, pharmacists, nurses, laboratory scientists, medical record offi cers and social welfare offi cers) at baseline (month 0) and 6 months post-intervention. Th e pre-and post -training questionnaire was administered to the healthcare professionals before and after the training intervention. Th e participants' training evaluation form was administered immediately after the capacity building for the evaluation of the training by the participants. Th e administration of the instruments was done by the researcher and three trained assistants.
Data Analysis
Predictive Analytics SoftWare (PASW) statistics-18 software was used for data analysis. Th e responses including those on 5-point Likert scales were analyzed using descriptive statistics on the sample characteristics and questionnaire items. Likert rating scale was anchored as follows: strongly agree = 5, agree = 4, neutral = 3, disagree = 2, and strongly disagree = 1 or always = 5, most of the time = 4, neutral = 3, rarely = 2, and never = 0; negatively worded items were reverse coded so that higher scores represent higher knowledge, attitudes and practices. Factor analysis was performed using principal components extraction. Missing values in the factor analysis was handled using listwise deletion. Factors selected had eigenvalues greater than 1. Items with factor loadings ≥0.40 were considered signifi cant, and loadings ≥ 0.50 were considered "very signifi cant" [30] . Mean item scores were computed for the individual attitude items. Paired samples t-test was used to compare the participants' knowledge, attitude and practice before and after interventions. One sample t-test was used to compare participants' attitudes within group. A midpoint of 3.6 was used for the 5-point scale which was determined by adding all the scores and computing the average. Mean attitude scores above the midpoint of 3.6 were regarded as positive attitude while scores below this mid-point were regarded as negative attitude. Th e reliability analysis was determined using Cronbach's alpha. All reported P values were 2-sided and P<0.05 used to determine statistical signifi cance.
RESULTS
Th irty six (36) healthcare professionals participated in the 5-day capacity building intervention; 22 (61.1%) were males and 14 (38.9%) were females. Th ese healthcare professionals included 16 (44.4%) medical doctors, 5 (13.9%) Pharmacists, 7 (19.4%) nurses, 3 (8.3%) laboratory scientists, 3 (8.3%) medical record offi cers and 2 (5.6%) were social welfare offi cers. Th e mean age of the participants was 36.6 (95%CI, 34.5-38.7) years.
Knowledge of the participants before and after the training intervention
Of the 36 participants who completed the pre-training knowledge evaluation, only 35 (97.2%) of them completed the post-training knowledge evaluation. Th e participants' mean pre-test score was 53.6% (95%CI, 44.6-63.6) which increased after the training to a mean post-test score of 77.1% (95%CI, 72.8-81.4); and the mean percent knowledge change was 146.9% (95% CI, 60.5-233.3). Th e knowledge increase was statistically signifi cant (p=0.000). None of the participants reported to have received training on pharmacovigilance previously, except the pharmacists who remarked that some pharmacists in the pharmacy department had received a training that included management of ADRs related to antiretroviral drugs as a topic in a broader Pharmaceutical Care in HIV training package.
Participants' Evaluation of the Training workshop
On a 5-point scale, the participants' overall rating of the training workshop was 4.5 (95%CI, 4.3-4.7); the topics covered in the training was rated 4.9 (95%CI, 4.8-5.0); organization of learning experience was 4.3 (95%CI, 4.1-4.5); length or space of schedule was 4.2 (95%CI, 4.0-4.4); presentations and explanation was 4.4 (95% CI, 4.2-4.6); opportunity to participate in discussions was 4.7 (95%CI, 4.5-4.9); accessibility and availability of trainers for clarifi cations was 4.6 (95%CI, 4.4-4.8); transport and accessibility to workshop venue was 4.2 (95%CI, 3.9-4.5); and meals provided was rated 3.9 (95%CI, 3.7-4.1). Th e participants' ratings of the content and relevance of the topics covered at the training workshop were 4.6 (95%CI, 4.4-4.8) for Drug regulation and pharmacovigilance in Nigeria; 4.6 (95%CI, 4.4-4.8) for Overview of pharmacotherapeutics of HIV/AIDS; 4.7 (95%CI, 4.5-4.9) for Drug interactions and pharmacovigilance; 4.8 (95%CI, 4.7-4.9) for Pharmacovigilance: Medication error and Adherence; 4.7 (95%CI, 4.5-4.9) for Establishing pharmacovigilance systems in a clinical setting; 4.8 (95%CI, 4.6-5.0) for Diagnosis and management of common ADRs related to ART; 4.5 (95%CI, 4.3-4.7) for Laboratory monitoring and pharmacovigilance; 4.5 (95% CI, 4.3 -4.7) for Reporting to the regulatory authorities; 4.5 (95%CI, 4.3-4.7) for Understanding signal and benefi t-risk determinations; 4.6 (95%CI, 4.4-4.8) for Monitoring and evaluation of safety data; 4.6 (95%CI, 4.4-4.8) for Standard operating procedure for detecting, evaluating and reporting ADRs and 4.6 (95%CI, 4.4-4.8) for Eff ective communications in pharmacovigilance.
Attitudes and Practices of Health Workers about ADRs monitoring and reporting
Of the 36 healthcare professionals who participated in the capacity building intervention, only 33 (91.7%) of them completed the KAP questionnaire at both pre-intervention (baseline) and 6 months postintervention. Th ere were 21 (63.6%) males, 15 (45.5%) medical doctors and 25 (75.8%) were aged 30 -39 years old (Table 1) . Th e estimated mean number of patients' contacts with participants per month was 521.4 (95%CI, . Table 2 compared the frequency distribution of participants' attitudes towards ADR monitoring and reporting in clinical practice before and after interventions. Th e overall rated scores mean of the participants' attitudes to ADR monitoring and reporting in clinical practice at pre-intervention was 3.6 (95%CI, 3.4-3.8; p=0.000); this increased to 4.2 (95%CI, 4.0-4.4; p=0.000) at post-intervention (Table 3) . Overall, the diff erence in participants' attitudes to ADR monitoring and reporting in clinical practice before and after interventions was statistically signifi cant (p=0.000) - Table 3 . Th e internal consistency of the 28-items attitude scale as measured by Cronbach's alpha was 0.710; also the average measures of Intraclass Correlation Coeffi cient (ICC) was 0.710 (95%CI, 0.509-0.856; p=0.000). Following the listwise deletion of missing values, 23 and 20 cases were left for factor analysis at pre-intervention and post-intervention respectively. Using the criterion of an eigenvalue greater than 1.0, nine and eight factors were extracted which accounted for 85.6% and 87.0% of variance at pre-intervention and post-intervention respectively. All communalities at pre-intervention and post-intervention assessments were 0.70 or greater. At pre-intervention, the large fi rst factor accounted for 21.1% of the variance. Th e second to ninth factors accounted for 14.6%, 11.8%, 10.5%, 7.5%, 6.2%, 5.6%, 4.6% and 3.7% of the variance, respectively. However, the scree plot indicated a break after the ninth factor (eigenvalue = 0.852). At post-intervention, the large fi rst factor accounted for 30.9% of the variance. Th e second to eighth factors accounted for 14.6%, 10.6%, 9.1%, 7.2%, 5.8%, 5.2% and 3.6% of the variance, respectively. However, the scree plot indicated a break after the eight factor (eigenvalue = 0.910). All items had one factor loading of 0.40 or greater (Tables 4 and 5 ). At pre-intervention, only 10 (30.3%) of the participants reported the existence of a functioning hospital-based pharmacovigilance committee or any committee responsible for co-ordination of ADR monitoring and pharmacovigilance program. However, the participants reported that the committee was not multidisciplinary as it comprised mainly of medical doctors and pharmacists. Th e participants that reported the existence of the committee were 6 (40.0%) of the medical doctors, 3 (100.0%) of the pharmacists and 1(14.3%) of the nurses. On the other hand, 31 (93.9%) of the participants reported the existence of a multidisciplinary and functioning pharmacovigilance committee co-ordinating ART pharmacovigilance program in the hospital at post-intervention. Only two participants (a nurse and a social welfare of- fi cer) reported otherwise. Th e diff erences in the participants' responses to the existence of a functioning hospital pharmacovigilance committee before and after intervention was statistically signifi cant (p=0.001). Of the participants, 25 (75.8%) reported that ADR reporting form were not readily available in the hospital at pre-intervention assessment compared to 6 (18.2%) at post-intervention assessment. Th e diff erences in the participants' response to the ready availability of ADR reporting form before and after intervention was statistically signifi cant (p = 0.000). At pre-intervention, ADR reporting forms were not handled by the medical record offi cers who are responsible for the coordination of hospital medical records, opening of the patient's hospital case folder and provision of all medical data collection and reporting tools. Th e medical record offi cers were not aware of the existence of ADR reporting forms. Th e ADR reporting form was mainly localized at the pharmacy and very scanty at the consulting clinics. At post-intervention, the participants reported a shift of the custody and provision of ADR reporting forms from pharmacy to medical record department for easy accessibility to all service delivery points. Of the participants, only 5 (15.2%) of them had reported ADR previously at pre-intervention assessment compared to 23 (69.7%) at post-intervention assessment. Of the participants who had reported ADR previously, only 2 (40.0%) kept record of all identifi ed and reported ADRs at pre-intervention assessment, compared 22 (95.7%) reported at post intervention assessment. Th e participants who reported providing information regarding ADRs and its management routinely to patients increased from 4 (12.1%) at pre-intervention to 15 (45.5%) at post-intervention. Th is increase was statistically signifi cant (p=0.000) - Table 6 . Of the participants, 7 (21.2%) of the participants reported having standard operating procedure (SOP) for detecting, evaluating and reporting ADRs in the hospital at pre-intervention compared to 31 (93.9 %) at post-intervention. Th is increase was statistically signifi cant (p = 0.012).
DISCUSSION
Th e study evaluated the change in knowledge, attitudes and practices of healthcare professionals about ADR monitoring and reporting after six months of interventions. Majority of the participants were not trained on ADR monitoring and reporting previously. However, about onehalf of the participants had over 6 years of professional experience. Th e identifi ed barriers to ADR monitoring and reporting in clinical practice at pre-intervention assessment were lack of knowledge, unavailability of reporting forms and ignorance of the reporting procedure.. Th ese barriers were consistent with previous research fi ndings [18, 24, 25] . Following the interventions, change in the participants' knowledge of ADR monitoring and pharmacovigilance increased by over 100% after the training intervention which was statistically signifi cant. Th is knowledge increase was consistent with the overall rating of the training workshop by majority of the participants as above average to excellent. Th e topics covered in the training, its content and relevance were rated as excellent by majority of the participants. In general, the participants reported negative attitudes to ADR monitoring and reporting in clinical practice at pre-intervention. Th is is consistent with previous research fi ndings [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . However, some of the participants had mean rated scores which denotes positive attitudes to ADR monitoring and reporting in some of the attitude items at pre-intervention. At post-intervention, almost all the participants had positive attitudes towards ADR monitoring and reporting in clinical practice. Th e difference in participants' attitudes to ADR monitoring and reporting in clinical practice before and after interventions was statistically significant. However, the participants were inclined to having a mandatory ADR screening policy and the introduction of ADR screening form for active ADR surveillance in clinical practice at both pre-and postintervention. Similarly, the participants did not agree to the assertion that "healthcare professionals in general are insuffi ciently familiar with the monitoring of ADRs to adequately deal with it in clinical practice" at both pre-and post-intervention. Th is is consistent with the baseline pre-training knowledge assessment score of slightly over 50% recorded by the participants. Almost all the participants reported the existence of a functioning hospital-based pharmacovigilance committee or any committee responsible for co-ordination of ADR monitoring and pharmacovigilance program at post-intervention compared to less than onethird of the participants at pre-intervention. However, the participants who reported the existence of the committee at pre-intervention indicated that the membership was not multidisciplinary as it comprised mainly of medical doctors and pharmacists. Th is is contrary to a multidisciplinary and functioning hospital-based pharmacovigilance committee which held monthly ADR data review and feedback meetings at post-intervention. Th is diff erence was statistically signifi cant and may have contributed to an improved coordination of ADR monitoring and reporting in the hospital at post-intervention. About three-quarter of the participants reported that ADR reporting form were not readily available in the hospital at pre-intervention assessment compared to less than one-fi fth reported at the post-intervention assessment. Th is was a signifi cant improvement as unavailability and lack of knowledge of the ADR reporting form were reported as causal to low ADR reporting rates in previous studies [24, [26] [27] [28] . Th e shift of the custody of ADR reporting form and its distribution to all service delivery points from pharmacy to medical record department which had no knowledge of this tool previously may have contributed to its ready availability at post-intervention assessment. At pre-intervention, less than one-sixth of the participants had reported ADR previously which is higher than what previous studies reported in Nigeria [26, 28] . However, this fi gure is lower than slightly over two-third of the participants who had reported ADR previously at post-intervention assessment and somewhat similar to what was reported in a developed country [33] . Th is increase was statistically signifi cantly. Majority of the participants reported providing information regarding ADRs and its management routinely to patients at post-intervention compared to the baseline. Almost all the participants reported having SOP for detecting, evaluating and reporting ADRs in the hospital at post-intervention compared to about onefi fth of participants at pre-intervention. Th e internal consistency of the attitude items was acceptable [31] and fairly superior to 0.70 indicating that the items are suffi ciently correlated to constitute a scale [32] . All attitude items had one factor loading of 0.40 or greater which may indicate that the extracted factors represented the variables well [30] . Th e extracted factors at pre-and post-interventions reduced the complexity of the dataset with a 14.4% and 13.0% loss of information respectively. Th e sample sizes for each category of healthcare professionals were small and limited comparative analysis between groups. Th ere may be response bias. Some participants may deliberately give false information to place themselves or the hospital in a good or bad position. Th is may overestimate or underestimate the measure of eff ects or the rated scores mean. Th ere may also be selection bias when selecting the study site and participants. Th is may aff ect the generalization of the study fi ndings. Th ere may be recall bias by some participants when responding to the questions in the instrument. Th is has the potential to either overestimate or underestimate the eff ects been measured.
CONCLUSION
Th e study interventions resulted in signifi cant improvement in ADR monitoring and reporting in clinical practice in this setting. Lack/inadequate knowledge, unavailability of reporting forms, and ignorance of the reporting procedure were barriers to ADR monitoring and reporting in ADR is the patients' problem for which they should worry about and take responsibility 4.2 (3.8 -4.6) 4.1 (3.7 -4.5) 0.823 ADR monitoring is a phenomenon that concerned only chronically ill patients on life-long medication and should be confi ned to them 4.2 (3.8 -4.6) 4.3 (3.9 -4.7) 0.757
It is my professional responsibility to screen patients for ADR 4. 1 (3.8 -4.4 clinical practice. Addressing these barriers led to signifi cant improvement in knowledge, attitudes and practices of healthcare professionals about ADR monitoring and reporting in clinical practice. Healthcare workers were more willing to practice pharmacovigilance following the intervention. Scaling up these interventions to other hospitals can better the situation of under-reporting of ADRs in Nigeria.
